Dr. Daniel Bouthillier has over 30 years of experience in research administration. He currently serves as Vice President, Research at Devonian Health Group Inc. Previously, he co-founded Kaneq Pharma and Kaneq Bioscience. Dr. Bouthillier held several leadership positions at Merck & Co., including Executive Director of Research Administration and Planning for multiple research sites across North America, and Executive Director of Global Facilities Management, overseeing operations in Canada, the United States, South America, and Asia.
Earlier in his career, he served as Senior Scientist and Administrator at the Clinical Research Institute of Montreal, and as Head of Biochemistry at both Hôtel-Dieu de Sorel and Fleury Hospital in Montreal.
He serves on numerous evaluation committees and boards, including the Centre québécois d’innovation en biotechnologie (CQIB) and Kanyr Pharma. Mr. Bouthillier holds a Ph.D. in Clinical Sciences from the Université de Montréal and is certified in Clinical Biochemistry. He also earned an MBA from HEC Montréal (École des Hautes Études Commerciales).